Neurocrine Biosciences (NBIX)

Neurocrine Biosciences (NBIX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• NBIX last traded at $145.63, -0.32% on the day.
• Neurocrine Biosciences: market cap $14.85B, P/E 20.8, revenue $3.37B over the last four quarters, next earnings 2026-11-02.
• Over the past year NBIX returned 5.50%; year to date 2.68%.

Updated 2026-11-02 18:02 UTC